Introduction: Adverse events. such as erectile dysfunction (ED) and lower urinary tract symptoms (LUTS). are significant concerns in prostate cancer (PCa) patients treated with Iodine 125 (I-125) low-dose rate (LDR) prostate brachytherapy (PB). Alpha antagonists and phosphodiesterase-5 inhibitors are used to manage these events. https://foldlyers.shop/product-category/house/